ELI
TMO icon

Empire Life Investments’s Thermo Fisher Scientific TMO Stock Holding History

Empire Life Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,127
Closed -$8.26M – 97
2019
Q2 		$8.26M Buy
28,127
+5,174
+23% +$1.43M 0.67% 52
2019
Q1 		$6.28M Buy
22,953
+258
+1% +$64.2K 0.53% 54
2018
Q4 		$5.08M Sell
22,695
-1,020
-4% -$239K 0.46% 64
2018
Q3 		$5.79M Buy
23,715
+325
+1% +$74.8K 0.44% 61
2018
Q2 		$4.84M Buy
23,390
+370
+2% +$78.5K 0.35% 73
2018
Q1 		$4.75M Sell
23,020
-59,758
-72% -$12.5M 0.34% 70
2017
Q4 		$15.7M Buy
82,778
+1,989
+2% +$381K 1.21% 34
2017
Q3 		$15.3M Sell
80,789
-818
-1% -$148K 1.24% 34
2017
Q2 		$14.2M Buy
81,607
+29,103
+55% +$4.89M 1.24% 36
2017
Q1 		$7.86M Buy
52,504
+29,875
+132% +$4.57M 0.77% 48
2016
Q4 		$3.16M Buy
+22,629
New +$3.34M 0.26% 67

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Empire Life Investments's TMO Position: Q3 2019 in Review

Empire Life Investments sold out of Thermo Fisher Scientific (TMO) in Q3 2019, closing a stake of 28,127 shares — an estimated $8.26M sold.

Empire Life Investments first reported a position in TMO in Q4 2016 and held it in 11 quarters. The position peaked at $15.7M in Q4 2017. 1,544 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Empire Life Investments reported no remaining Thermo Fisher Scientific position as of Q3 2019 after selling out during the quarter.
  • Empire Life Investments sold 28,127 Thermo Fisher Scientific shares in Q3 2019, an estimated $8.26M.
  • Empire Life Investments first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 11 quarters.
  • Empire Life Investments's Thermo Fisher Scientific position peaked at $15.7M in Q4 2017.
  • 1,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Empire Life Investments's 13F filing for Q3 2019, filed 25 Oct 2019.